• $32.4M
    Market Cap
  • -33.12%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
355.6M
-8.52%
388.7M
+76.93%
Cost of Revenue
229.5M
+12.92%
203.3M
-17.78%
247.2M
+7.61%
229.7M
+85.73%
Gross Profit
33.2M
+9.75%
30.2M
-71.23%
105.1M
-32.23%
155.1M
+70.18%
Sales and Marketing Expense
52.5M
-3.17%
54.2M
+1.79%
53.3M
-5.77%
56.5M
+143.53%
Research and Development Expense
-390,000
-5.80%
-414,000
+6.70%
-388,000
-38.61%
-632,000
-48.83%
Depreciation and Amortization Expense
17.1M
+11.56%
15.4M
+16.75%
13.2M
+12.54%
11.7M
+58.24%
Total Operating Expenses
40.9M
-23.81%
53.7M
+25.95%
42.6M
+18.09%
36.1M
+32.63%
Operating Profit
N/A
N/A
N/A
N/A
-41.6M
-182.10%
50.6M
+79.62%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-7,000
-70.83%
Interest Income and Expense and Net
0
N/A
0
N/A
0
+100.00%
-7,000
-70.83%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
33.9M
+483,985.71%
7,000
-99.19%
Income before Taxes
-36.8M
-49.47%
-72.8M
+14.58%
-63.5M
-245.22%
43.7M
+499.88%
Income Taxes
-7.3M
-49.63%
-14.5M
-746.35%
2.2M
+2,317.20%
93,000
-99.19%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-36.8M
-49.47%
-72.8M
+14.58%
-63.5M
-245.22%
43.7M
+499.88%
Net Income from Continuing Operations Applicable to Common
-36.8M
-49.47%
-72.8M
+14.58%
-63.5M
-245.22%
43.7M
+499.88%
Basic EPS and Net Income
-0.66
-55.41%
-1.48
+8.82%
-1.36
-237.37%
0.99
+725.00%
Diluted EPS and Net Income
-0.66
-55.41%
-1.48
+8.82%
-1.36
-237.37%
0.99
+800.00%
Basic Weighted Average Shares
53.7M
+17.17%
45.9M
+0.65%
45.6M
+0.49%
45.4M
+17.82%
Diluted Weighted Average Shares
53.7M
+17.17%
45.9M
+0.65%
45.6M
+0.49%
45.4M
+17.82%
Balance Sheet
Cash and Cash Equivalents
46.5M
N/A
N/A
N/A
101.1M
-56.52%
232.6M
+18.54%
Short-Term Investments
N/A
N/A
N/A
N/A
187,000
+19.11%
157,000
-52.42%
Cash and Cash Equivalents and Short-Term Investments
46.5M
N/A
0
-100.00%
101.3M
-56.46%
232.7M
+18.42%
Total Current Assets
45.2M
-88.46%
391.8M
-6.45%
418.8M
-17.48%
507.5M
+50.97%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
7.2M
+1.26%
7.1M
-92.67%
97.5M
-5.49%
103.1M
+19.22%
Total Long-Term Assets
373.8M
+0.82%
370.8M
+0.81%
367.8M
-18.36%
450.5M
+28.66%
Total Assets
690.6M
-9.44%
762.6M
-3.06%
786.6M
-17.89%
958.0M
+39.59%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
88.8M
+27.89%
69.4M
-21.27%
88.2M
-30.52%
126.9M
+79.90%
Total Current Liabilities
214.4M
-5.46%
226.8M
+0.39%
225.9M
-27.77%
312.7M
+61.54%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
79.8M
-42.22%
138.2M
+33.24%
103.7M
-16.26%
123.8M
+269.06%
Total Liabilities
N/A
N/A
364.9M
+10.73%
329.6M
-24.51%
436.5M
+92.19%
Retained Earnings
-314.6M
+13.34%
-277.6M
+36.07%
-204.0M
+44.01%
-141.6M
-24.04%
Total Stockholders Equity
396.4M
N/A
N/A
N/A
457.1M
-12.35%
521.5M
+13.56%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
16.8M
+125.16%
-66.9M
+24.79%
-53.6M
-204.61%
51.3M
+104.91%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2.0M
-111.26%
17.7M
+270.61%
4.8M
+103.35%
-142.5M
+118.52%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-46.7M
-276.37%
26.5M
+131.92%
-82.9M
-168.82%
120.4M
-40.68%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
30.47%
-25.49%
40.90%
N/A
Operating Margin
N/A
N/A
N/A
N/A
-11.69%
-189.76%
13.03%
N/A
Return on Assets
-5.06%
-46.13%
-9.40%
+29.03%
-7.28%
-236.87%
5.32%
N/A
Return on Equity
N/A
N/A
N/A
N/A
-12.99%
-245.54%
8.92%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
-8.52%
-111.08%
76.93%
N/A
Current Ratio
0.21
-87.79%
1.73
-6.81%
1.85
+14.26%
1.62
N/A
Cash Ratio
0.22
N/A
N/A
N/A
0.45
-39.80%
0.74
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow